No products in the cart.
Lysine Acetylsalicylate for Injection 0.25?g – Research-Use Only
$1.00
Lysine Acetylsalicylate is a water-soluble form of acetylsalicylic acid (aspirin) developed for intravenous administration. This formulation offers rapid onset and improved gastrointestinal tolerability compared to oral aspirin. Intended solely for laboratory research applications.
Description
Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Lysine Acetylsalicylate for Injection |
| CAS Number | 62952-06-1 |
| Molecular Formula | C??H??N?O? |
| Molecular Weight | 326.34 g/mol |
| Dosage Form | Sterile aqueous solution for intravenous injection |
| Strength | 0.25?g per vial |
| Pack Size | 1 vial per box |
| Approval Number | H22023727 (China NMPA) |
| Product Code | 86903356000437 |
| Manufacturer | Jilin Aodong Tiaonan Pharmaceutical Co., Ltd. |
| Storage Conditions | Store at 2–8?°C; protect from light |
| Intended Use | Laboratory research only |
Mechanism of Action
Lysine Acetylsalicylate dissociates into acetylsalicylic acid (aspirin) and lysine upon administration. Aspirin exerts its pharmacological effects by irreversibly inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins and thromboxanes, thereby reducing inflammation, pain, and fever.
Research Applications & Pharmacology
Analgesic and Antipyretic Studies: Utilized in models assessing pain and fever mechanisms.
Anti-inflammatory Research: Investigates the compound’s effects on inflammatory pathways.
Pharmacokinetic Studies: Examines the absorption, distribution, metabolism, and excretion of the compound.
Toxicology Assessments: Evaluates potential adverse effects and safety profiles.
Safety Profile & Handling
Adverse Effects: May include gastrointestinal discomfort, bleeding tendencies, and hypersensitivity reactions.
Handling: Use appropriate personal protective equipment (PPE); follow institutional biosafety protocols.
Storage: Maintain at recommended temperatures; avoid exposure to light and moisture.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 18 × 16 × 18 cm |
Related products
Diclofenac Sodium Enteric?Coated Capsules 50?mg ×?30 Capsules Wholesale price comparison
Diclofenac sodium (Feiyan®, CCPC) is an NSAID formulated as enteric?coated capsules—designed to minimize gastric irritation. Each box includes 30 capsules of 50?mg each. Manufactured by Dequan Pharmaceutical (Jiangsu) Co., Ltd. Approved under NMPA H19990333, product code 86901751000076 (barcode?6924373920144).
?? For laboratory research use only.?Please consult the staff for other purposes? $2.00Celecoxib Capsules 1.2g – Grade COX?2 Inhibitor
Celecoxib is a selective COX?2 inhibitor (NSAID) commonly used in preclinical research to study inflammation, pain, cancer prevention, and cardiovascular risk. Each capsule contains 200?mg celecoxib. ?? For laboratory research use only.?Please consult the staff for other purposes? $1.00Bupivacaine Hydrochloride 37.5?mg ×?5 Vials Wholesale price comparison
Bupivacaine hydrochloride is a long-acting amide-type local anesthetic widely used in preclinical studies for nerve block, infiltration, epidural, and spinal anesthesia. Each box contains five 5?mL vials (37.5?mg per vial). Manufactured by Hunan Zhengqing Pharmaceutical Group Co., Ltd., approved under NMPA H43021018, product code 86904152004254.
?? For laboratory research use only.?Please consult the staff for other purposes? $2.00Cisatracurium Besilate 10?mg / 5?mL Vial Wholesale price comparison
Cisatracurium besilate is an intermediate-acting, non-depolarizing neuromuscular blocking agent used in preclinical research for muscle relaxation, anesthesia modeling, and mechanical ventilation studies. It is one of the 10 stereoisomers of atracurium, offering greater potency and minimal histamine release. Each 5?mL vial contains 10?mg.
?? For laboratory research use only.?Please consult the staff for other purposes? $23.00
Reviews
There are no reviews yet.